Market data

Select a section

Redx Pharma

(REDX)
Sector: Pharmaceuticals & Biotechnology
15.00p
3.60p 31.58
Last updated: 17:06:54

Company News Headlines

Date Time Headline Source
01/05/2024 07:00 Cancellation - Redx Pharma Plc RNS
30/04/2024 17:46 Share Purchases by a PDMR RNS
30/04/2024 07:00 Share Purchases by PDMR’s RNS
29/04/2024 07:00 Update on AIM Delisting RNS
22/04/2024 17:45 TR-1: Notification of major holdings RNS
19/04/2024 12:18 Result of GM, Cancellation of Admission to Trading RNS
18/04/2024 07:00 Share Purchases by a Director RNS
12/04/2024 07:00 Share Purchase by a Director RNS
10/04/2024 07:00 Update on Broking Arrangements RNS
08/04/2024 15:32 TR-1: Notification of major holdings RNS
02/04/2024 07:00 Proposed Cancellation of Admission to Trading RNS
14/03/2024 11:27 Result of AGM RNS
06/03/2024 07:00 Redx to Exhibit Three Posters at AACR RNS
28/02/2024 07:00 First Participant Dosed in Phase 1 Trial of RXC008 RNS
23/02/2024 07:00 New Grant of Options RNS
16/02/2024 16:50 Notice of AGM RNS
14/02/2024 07:00 Statement re Press Report RNS
08/02/2024 13:02 TR-1: Notification of major holdings RNS
07/02/2024 07:00 Redx announces sale of KRAS inhibitor program RNS
15/12/2023 07:00 Final Audited Results for Year Ended 30 September RNS
12/12/2023 07:00 Notice of Preliminary Results RNS
09/11/2023 07:00 Holdings in Company RNS
08/11/2023 13:58 TR-1: Notification of major holdings RNS
08/11/2023 13:55 TR-1: Notification of major holdings RNS
07/11/2023 08:10 Admission of Subscription Shares and TVR RNS
06/11/2023 11:22 Results of General Meeting RNS
18/10/2023 07:00 Proposed Subscription to raise c.£14.1 million RNS
22/08/2023 07:00 Directorate Change RNS
10/07/2023 07:00 Extension to Termination of Convertible Loan Notes RNS
03/07/2023 07:00 Directorate Change RNS
30/06/2023 07:00 New Grant of Options RNS
17/05/2023 07:00 Interim Results for the Six Months Ended 31 March RNS
10/05/2023 07:00 Notice of Interim Results RNS
03/04/2023 07:01 Proposed Business Combination Formally Lapsed RNS
03/04/2023 07:00 Termination of Proposed Business Combination RNS
30/03/2023 08:36 Form 8.5 (EPT/RI) - Redx Pharma plc RNS
27/03/2023 14:06 Statement Following Jounce Announcement RNS
27/03/2023 14:00 Statement re Merger Agreement RNS
24/03/2023 14:31 Form 8.3 - Jounce Therapeutics, Inc RNS
22/03/2023 14:20 Form 8.3 - Jounce Therapeutics, Inc RNS
20/03/2023 15:00 Form 8.3 - Jounce Therapeutics, Inc RNS
20/03/2023 10:38 Form 8.5 (EPT/RI) RNS
16/03/2023 09:48 Form 8.5 (EPT/RI) RNS
15/03/2023 16:40 Second Price Monitoring Extn RNS
15/03/2023 16:35 Price Monitoring Extension RNS
15/03/2023 14:05 Second Price Monitoring Extn RNS
15/03/2023 14:00 Price Monitoring Extension RNS
15/03/2023 10:50 Statement re: Jounce Therapeutics Press Release RNS
14/03/2023 11:45 Result of Annual General Meeting RNS
10/03/2023 07:00 Form 8.3 - Redx Pharma Plc RNS

Market data

Select a section